These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11055561)

  • 1. Risk of immediate effects from F(ab)2 bivalent antivenin in Taiwan.
    Chen JC; Bullard MJ; Chiu TF; Ng CJ; Liaw SJ
    Wilderness Environ Med; 2000; 11(3):163-7. PubMed ID: 11055561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the aggressive use of polyvalent antivenin for rattlesnake bites result in serious acute side effects?
    Offerman SR; Smith TS; Derlet RW
    West J Med; 2001 Aug; 175(2):88-91. PubMed ID: 11483547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antivenin-related serum sickness.
    Huang CY; Hung DZ; Chen WK
    J Chin Med Assoc; 2010 Oct; 73(10):540-2. PubMed ID: 21051032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poisonous snakebite in central Texas. Possible indicators for antivenin treatment.
    White RR; Weber RA
    Ann Surg; 1991 May; 213(5):466-71; discussion 471-2. PubMed ID: 2025067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications of Crotalidae antivenin therapy.
    Jurkovich GJ; Luterman A; McCullar K; Ramenofsky ML; Curreri PW
    J Trauma; 1988 Jul; 28(7):1032-7. PubMed ID: 2899649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First clinical experiences with specific sheep Fab fragments in snake bite. Report of a multicentre study of Vipera berus envenoming.
    Karlson-Stiber C; Persson H; Heath A; Smith D; al-Abdulla IH; Sjöström L
    J Intern Med; 1997 Jan; 241(1):53-8. PubMed ID: 9042094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Events in the Efficacy of Crotalidae Polyvalent Immune Fab Antivenom vs Placebo in Recovery from Copperhead Snakebite Trial.
    Mullins ME; Gerardo CJ; Bush SP; Rose SR; Greene S; Quackenbush EB; Lewis B; Anderson VE; Kleinschmidt KC; Schwarz RB; Charlton NP; Toschlog EA; Sharma K; Denning DA; Lavonas EJ
    South Med J; 2018 Dec; 111(12):716-720. PubMed ID: 30512122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influential factors affecting prognosis of snakebite patients management: Kaohsiung Chang Gung Memorial Hospital experience.
    Liao WB; Lee CW; Tsai YS; Liu BM; Chung KJ
    Chang Gung Med J; 2000 Oct; 23(10):577-83. PubMed ID: 11126148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hypersensitivity reactions associated with administration of crotalidae polyvalent immune Fab antivenom.
    Cannon R; Ruha AM; Kashani J
    Ann Emerg Med; 2008 Apr; 51(4):407-11. PubMed ID: 18191286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of antivenom for snakebites reported to United States poison centers.
    Spiller HA; Bosse GM; Ryan ML
    Am J Emerg Med; 2010 Sep; 28(7):780-5. PubMed ID: 20837254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful venomous snakebite neutralization with massive antivenin infusion in a child.
    Buntain WL
    J Trauma; 1983 Nov; 23(11):1012-4. PubMed ID: 6632024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a new ovine antigen binding fragment (Fab) antivenin for United States Crotalidae with the commercial antivenin for protection against venom-induced lethality in mice.
    Consroe P; Egen NB; Russell FE; Gerrish K; Smith DC; Sidki A; Landon JT
    Am J Trop Med Hyg; 1995 Nov; 53(5):507-10. PubMed ID: 7485708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse reactions to equine-derived F(ab')2 -antivenin in 54 dogs envenomated by Vipera berus berus.
    Lund HS; Kristiansen V; Eggertsdóttir AV; Skancke E; Ranheim B
    J Vet Emerg Crit Care (San Antonio); 2013; 23(5):532-7. PubMed ID: 24102941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of thai cobra bites with a single bolus of antivenin.
    Pochanugool C; Limthongkul S; Wilde H
    Wilderness Environ Med; 1997 Feb; 8(1):20-3. PubMed ID: 11990132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of snake bites and antivenin use at a regional medical center.
    Watson LI; Spivey C; Menon CR; Kotwall CA; Clancy TV; Hope WW
    Am Surg; 2010 Jul; 76(7):755-8. PubMed ID: 20698386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of tolerance and effectiveness of a F(ab')(2) polyvalent antienom for African snake bites in Kindia, Guinea].
    Baldé MC; Chippaux JP; Boiro MY; Stock R; Massougbodji A
    Bull Soc Pathol Exot; 2012 Aug; 105(3):157-61. PubMed ID: 22359185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of allergic reactions to Crotalidae polyvalent immune Fab.
    Khobrani M; Huckleberry Y; Boesen KJ; Aljabri A; Alharthi M; Patanwala AE
    Clin Toxicol (Phila); 2019 Mar; 57(3):164-167. PubMed ID: 30260274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rattlesnake bites in children: antivenin treatment and surgical indications.
    Shaw BA; Hosalkar HS
    J Bone Joint Surg Am; 2002 Sep; 84(9):1624-9. PubMed ID: 12208920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute adverse events associated with the administration of Crotalidae polyvalent immune Fab antivenom within the North American Snakebite Registry.
    Kleinschmidt K; Ruha AM; Campleman S; Brent J; Wax P;
    Clin Toxicol (Phila); 2018 Nov; 56(11):1115-1120. PubMed ID: 29688079
    [No Abstract]   [Full Text] [Related]  

  • 20. Venomous snakebite in a patient allergic to horse serum.
    Otten EJ; McKimm D
    Ann Emerg Med; 1983 Oct; 12(10):624-7. PubMed ID: 6625264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.